309 related articles for article (PubMed ID: 34210599)
1. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT).
Bauersachs R; Gerlach HE; Heinken A; Hoffmann U; Langer F; Noppeney T; Pittrow D; Klotsche J; Rabe E
Eur J Vasc Endovasc Surg; 2021 Aug; 62(2):241-249. PubMed ID: 34210599
[TBL] [Abstract][Full Text] [Related]
2. Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT Study.
Rabe E; Hoffmann U; Schimke A; Heinken A; Langer F; Noppeney T; Pittrow D; Klotsche J; Gerlach HE; Bauersachs R;
Eur J Vasc Endovasc Surg; 2023 Nov; 66(5):697-704. PubMed ID: 37573936
[TBL] [Abstract][Full Text] [Related]
3. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial.
Beyer-Westendorf J; Schellong SM; Gerlach H; Rabe E; Weitz JI; Jersemann K; Sahin K; Bauersachs R;
Lancet Haematol; 2017 Mar; 4(3):e105-e113. PubMed ID: 28219692
[TBL] [Abstract][Full Text] [Related]
4. Urgent surgery versus anticoagulation for treatment of superficial vein thrombosis in patients with varicose veins.
Casian D; Bzovii F; Culiuc V; Gutu E
Vasa; 2022 May; 51(3):174-181. PubMed ID: 35418255
[No Abstract] [Full Text] [Related]
5. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Kreidieh F; Temraz S
Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum).
Cosmi B; Filippini M; Tonti D; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Palareti G;
J Thromb Haemost; 2012 Jun; 10(6):1026-35. PubMed ID: 22487001
[TBL] [Abstract][Full Text] [Related]
7. Impact of emergency department management of isolated superficial vein thrombosis of the lower limbs: a secondary analysis of data from the ALTAMIRA study.
Beddar Chaib F; Jiménez Hernández S; Pedrajas Navas JM; Lecumberri R; Guirado Torrecillas L; Alonso Valle H; Diego Roza S; Sendín Martín V; Rivera Núñez MA; Pedraza García J; Sánchez Díaz-Canel D; Ruiz Artacho P;
Emergencias; 2023 Apr; 35(2):109-116. PubMed ID: 37038941
[TBL] [Abstract][Full Text] [Related]
8. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
9. Management of superficial vein thrombosis.
Cosmi B
J Thromb Haemost; 2015 Jul; 13(7):1175-83. PubMed ID: 25903684
[TBL] [Abstract][Full Text] [Related]
10. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study.
Barco S; Pomero F; Di Minno MND; Tamborini Permunian E; Malato A; Pasca S; Barillari G; Fenoglio L; Siragusa S; Di Minno G; Ageno W; Dentali F
J Thromb Haemost; 2017 Nov; 15(11):2176-2183. PubMed ID: 28871623
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum).
Cosmi B; Filippini M; Campana F; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Legnani C; Palareti G;
Thromb Res; 2014 Feb; 133(2):196-202. PubMed ID: 24365043
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer.
Galanaud JP; Blaise S; Sevestre MA; Terrisse H; Pernod G; Gaillard C; Genty C; Monreal M; Rabah Y; Kahn SR; Quéré I; Bosson JL;
Thromb Res; 2018 Nov; 171():179-186. PubMed ID: 29789147
[TBL] [Abstract][Full Text] [Related]
13. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
Kirkilesis GI; Kakkos SK; Tsolakis IA
Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
[TBL] [Abstract][Full Text] [Related]
14. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis.
Di Minno MN; Ambrosino P; Ambrosini F; Tremoli E; Di Minno G; Dentali F
J Thromb Haemost; 2016 May; 14(5):964-72. PubMed ID: 26845754
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
Lu X; Lin J
BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis for the association between duration of anticoagulation therapy and the risk of venous thromboembolism in patients with lower limb superficial venous thrombosis.
Lobastov K; Dubar E; Schastlivtsev I; Bargandzhiya A
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101726. PubMed ID: 38008180
[TBL] [Abstract][Full Text] [Related]
18. Medical management of acute superficial vein thrombosis of the saphenous vein.
Scovell SD; Ergul EA; Conrad MF
J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):109-117. PubMed ID: 29097174
[TBL] [Abstract][Full Text] [Related]
19. Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin.
Karathanos C; Kakkos SK; Georgiadis G; Ioannou C; Vasdekis S; Chatzis D; Latzios P; Giannoukas AD;
Phlebology; 2023 Apr; 38(3):141-149. PubMed ID: 36461172
[TBL] [Abstract][Full Text] [Related]
20. Isolated Great Saphenous Vein Thrombus Is Associated with High Rates of Complications regardless of Management.
Kudlaty E; Oriowo B; Yang MJ; Go MR; Satiani B
Ann Vasc Surg; 2017 Nov; 45():154-159. PubMed ID: 28600022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
